TLR7 and hypertensive disorder: It has already been shown that gut microbiota, independently of SCFA production, contributes to the TLR7-driven raise in Th17 cells, kidney damage, endothelial dysfunction, vascular inflammation, and hypertension [24], and probiotics consumption decreased BP under TLR7 activation conditions [25].